Published in Oncotarget on December 01, 2015
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol (2016) 0.83
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified from reactive idiopathic hypereosinophilic syndrome. Haematologica (2017) 0.75
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations. Sci Rep (2017) 0.75
Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med (2013) 9.65
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) (1975) 9.01
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia (2007) 8.34
The idiopathic hypereosinophilic syndrome. Blood (1994) 4.65
DNA methylation analysis by pyrosequencing. Nat Protoc (2007) 4.65
The association of common variants in PCSK1 with obesity: a HuGE review and meta-analysis. Am J Epidemiol (2014) 2.07
Eosinophilia: secondary, clonal and idiopathic. Br J Haematol (2006) 1.82
The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol (2003) 1.78
The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J (2006) 1.73
Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. PLoS One (2010) 1.60
PUF60: a novel U2AF65-related splicing activity. RNA (1999) 1.59
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica (2013) 1.40
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32
Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65). PLoS One (2007) 1.28
Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med (2009) 1.24
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood (2011) 1.17
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol (2012) 1.15
Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J (2013) 1.14
Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol (2012) 1.12
Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med Genomics (2012) 1.11
Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. J Natl Cancer Inst (2013) 1.06
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica (2010) 1.02
World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management. Am J Hematol (2012) 0.92
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms. Haematologica (2013) 0.90
Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors. Anticancer Res (1995) 0.89
Gene dysregulation by histone variant H2A.Z in bladder cancer. Epigenetics Chromatin (2013) 0.88
Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network. Sci Rep (2013) 0.87
Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer. Epigenetics (2014) 0.87
The IL1alpha-S100A13 heterotetrameric complex structure: a component in the non-classical pathway for interleukin 1alpha secretion. J Biol Chem (2011) 0.84
Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes. Epigenomics (2014) 0.80
Hypereosinophilia. Ann Intern Med (1968) 0.76
Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation. Oncotarget (2015) 0.86
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years. Biol Blood Marrow Transplant (2016) 0.75
Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes. Am J Hematol (2016) 0.75